Antibiotics are widely used medications that treat various bacterial infections and prevent their spread. They are available in different formulations including capsules, tablets, solutions, and injectables. Some key applications of antibiotics include treatment of respiratory infections like pneumonia and infections of the skin, ears, urinary tract, and others. The growing demand for antibiotics to treat bacterial infections across the globe is driving their uptake.
The global antibiotics market is estimated to be valued at US$ 53803.25 Mn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increased usage of antibiotics is one of the key trends fueling the antibiotics market growth. According to the World Health Organization (WHO), antibiotic consumption has increased by 65% globally since 2000. Easy accessibility and overprescription of antibiotics are some of the primary factors behind rising usage. Improper and prolonged usage is contributing to the growing resistance to antibiotics, which poses a severe public health threat. However, growing awareness regarding antimicrobial resistance and implementation of regulations to curb overuse are expected to positively impact the usage rate going ahead.
Segment Analysis
The global antibiotics market is segmented into penicillin, cephalosporins, carbapenems, fluoroquinolones, and others. Among these, the cephalosporins segment dominated the market and accounted for over 30% share in 2023. Cephalosporins are widely prescribed as they are effective against broad-spectrum bacteria like staphylococci and streptococci. Their effectiveness and relatively fewer side effects have increased their adoption among patients and healthcare professionals.
Key Takeaways
The Global Antibiotics Market Size is estimated to be valued at US$ 53803.25 Mn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030.
Regional analysis
North America held the largest share in the global antibiotics market in 2023 owing to high healthcare spending and easy availability of broad-spectrum antibiotics. However, Asia Pacific is expected to witness the highest growth during the forecast period due to large patient population, rising healthcare expenditure, and increasing government focus on providing affordable treatment options.
Key players
Key players operating in the antibiotics market are Diageo plc, Brown-Forman, Pernod Ricard, Bacardi Limited, Suntory Holdings Limited, Asahi Group Holdings, Ltd., Anheuser-Busch InBev, E. & J. Gallo Winery, Constellation Brands, Inc., Treasury Wine Estates, Barefoot Cellars, and Kona Brewing Co. Diageo plc dominates the market with a wide product portfolio and global footprint. The company has been expanding its production capacity and distribution network to meet the growing demand.
Get More Insights Here
Greek
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)